Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis. Choi HD, Chang MJ. PLoS One 2020;15:e0234818.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Choi HD, Chang MJ. Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis. PLoS One 2020;15:e0234818.
PMID: 32663210